CARDIOVASCULAR GENETICS

Question 1

4q25-AF RISK GENOTYPE (90948)

Answer 1

Aids in the assessment of risk of atrial fibrillation and cardiometabolic stroke.

Question 2

9p21 GENOTYPE (90648)

Answer 2

Aids in the assessment of risk associated with myocardial infarction (MI), especially before age 50 in males and 60 in females.

Question 3

Apo E GENOTYPE (90649)

Answer 3

Determines the subtypes of ApoE which will aid in the risk assessment of coronary heart disease and hyperlipoproteinemia.

Question 4

CYP2C19 GENOTYPE (90668)

Answer 4

Used to help guide clopidogrel prescribing, especially in patients with acute coronary syndrome who have undergone percutaneous coronary intervention.

Most validated genetic determinant of clopidogrel response.

Question 5

KIF6 GENOTYPE (90645)

Answer 5

Detects a gene variant associated with elevated coronary heart disease risk and such CHD event can be reduced from atorvastarion and pravastation therapy.

Question 6

LPA-ASPIRIN GENOTYPE (90553)

Answer 6

Identifies individuals who are at risk of having elevated plasma lipoprotein (a) and elevated CVD risk which could be reduced by low dose aspirin therapy.

Question 7

LPA-INTRON 25 GENOTYPE (90655)

Answer 7

Identifies patients at risk for elevated lipoprotein (a) and elevated CVD risk.